The Easy Liver Fibrosis Test (eLIFT) for predicting advanced liver fibrosis in patients with chronic hepatitis B.
Lists
Only you see this
Abstract
eLIFT as a novel index can predict advanced liver fibrosis with a moderate sensitivity and accuracy in CHB patients. eLIFT, though having similar diagnostic values of advanced liver fibrosis compared to more complex existing tools such as APRI, FIB-4, GPR, and RPR in CHB patients, has the advantage of clarity of generation and ease of application and has the potential of being widely used by hepatologists.
BibTeX
@inproceedings{wang2019easy,
author = {Jian Wang and Zhong Chen and Xiaomin Yan and Yue Yang and Yong Liu and Yuxin Chen and Bei Jia and Juan Xia and Yali Xiong and Zhaoping Zhang and Weimao Ding and Rui Huang and Chao Wu},
title = {{The Easy Liver Fibrosis Test (eLIFT) for predicting advanced liver fibrosis in patients with chronic hepatitis B.}},
booktitle = {PubMed},
year = {2019},
}Loading related content...